ask our doctors

Acute Myelogenous Leukemia

Get the facts on Acute Myelogenous Leukemia treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Acute Myelogenous Leukemia prevention, screening, research, statistics and other Acute Myelogenous Leukemia related topics. We answer all your qestions about Acute Myelogenous Leukemia.

Question: how rear is it in a child that they have both acute lymphocytic leukemia (ALL) and acute myelogenous leukemia? my friends sister was diagnosed with both of those leukemia's and apparently its rear. how rear is it and will she be ok?

Answer: Well it's very rare because they're both leukemias, and both acute, but they effect different kinds of white blood cells. She will probably need 2 kinds of chemotherapy, and possibly a bone marrow or stem cell transplant. Both are curable (AML is harder to cure than ALL), but if both have been caught early, it'll be a long hard and intense fight, but she can make it and live a totally normal life afterwards.


Acute Myelogenous Leukemia News

FDA Panel To Review Eisai Blood Drug Dacogen; Agency Says Study Failed

Wall Street Journal
TO, ESALY) proposal to expand the use of its blood drug Dacogen for use in treating older patients with acute myelogenous leukemia, a type of blood cancer. Dacogen is currently approved to treat a blood disorder called myelodysplastic syndromes, ...
 

Bio-Path completes second cohort dosing of leukemia drug trial

Pharmaceutical Business Review
Liposomal Grb-2 is indicated as a systemic treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS). The second cohort of the Phase I ...
 

Benzene Leukemia Lawsuit Filed Over Hazardous Workplace

InjuryBoard.com
Exposure to benzene has been associated with the development of several fatal forms of cancer, leukemia and other conditions, such as Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphocytic Leukemia (ALL), ...
 

KSTP.com

Roseville Spaghetti Dinner Raises Money for Transplant Recipient
KSTP.com
 

Critical Outcome Technologies Initiates AML Drug Candidates Preclinical Testing

TechFinance
Critical Outcome Technologies Inc. (COTI) (TSX-V: COT) has initiated confirmatory preclinical tests, representing an important step forward in the development of synthesis of compounds from its acute myelogenous leukemia (AML) program.
 

OneMedPlace (blog)

This Week In Diagnostics
OneMedPlace (blog)
 

Nassau Guardian

Mother of two diagnosed with acute myeloid leukemia in need of bone marrow ...
Nassau Guardian
 

COTI completes compound synthesis in AML program

Pharmaceutical Business Review
Critical Outcome Technologies (COTI) has completed synthesis of compounds from its acute myelogenous leukemia (AML) program and initiated confirmatory preclinical tests. According to the company, AML program has the potential to produce multiple drug ...
 

BioLife Solutions Congratulates DCPrime on Its Approved Orphan Medicinal ...

MarketWatch (press release)
"This orphan drug designation is a major step in DCPrime's work towards approval of our AML vaccine, and clearly reflects the COMP's view of the potential of this vaccine in improving survival of patients with AML," said DCPrime Chief Executive Officer ...
 

PhysOrg.com

Researchers discover the processes leading to acute myeloid leukemia
PhysOrg.com